Patients are no longer passive recipients of medical information. They increasingly search for information about symptoms, diagnostic tests, treatment options, side effects, and long-term disease management before, during, and after clinical encounters. This creates an important responsibility for Medical Affairs: scientific information must not only be accurate, but also understandable, accessible, and relevant to the questions patients are actually asking.

The challenge becomes even greater when an organisation enters a disease area for the first time. A new therapeutic launch may bring strong clinical evidence, but the organisation may have limited understanding of how patients experience diagnosis, where uncertainty arises along the care pathway, or which scientific concepts are most frequently misunderstood. Developing educational materials without that knowledge risks producing technically accurate content that fails to address the real information gap.

Patient education, therefore, needs to begin before content creation. Medical Affairs can play a leading role by understanding the patient pathway, identifying areas of uncertainty, and ensuring that scientific communication reflects real patient needs. A short video explaining a diagnostic concept in a patient’s preferred language may be far more useful than a detailed brochure, but only when it addresses the confusion patients genuinely experience rather than the questions an organisation assumes they have.

Step One: Identifying the Knowledge Gap

Effective patient education starts with understanding what patients already know and, equally importantly, what they misunderstand. This assessment should extend beyond general disease awareness to the complete patient journey. Patients may understand the name of their condition while remaining uncertain about how the diagnosis was reached, why particular tests were performed, what different results mean, or what happens between referral and treatment initiation.

Medical Affairs can build this baseline through structured patient interviews, surveys, patient advocacy group feedback, and review of recurring questions raised in patient communities. Mapping the pathway from symptom recognition through primary care, referral, diagnostic testing, specialist assessment, and treatment decision can reveal where uncertainty or anxiety is greatest. These assessments should also be repeated across markets because healthcare systems, diagnostic pathways, cultural expectations, and information needs may differ significantly.

The findings can change the direction of an education strategy. A gap analysis might show, for example, that patients understand the available treatments relatively well but remain confused about why a particular diagnostic test is required or what a borderline result means. In that situation, another broad disease-awareness resource adds little value. The priority becomes explaining the diagnostic process clearly and at the point when patients need that information most.

Step Two: Bringing KOLs and Patient Advocacy Groups Together

Once the information gaps are understood, the next challenge is determining how scientific information should be presented. Medical Affairs has an important coordinating role, but content development should not take place in isolation. Both clinical experts and patient representatives bring perspectives that are difficult to reproduce internally.

Key opinion leaders (KOLs) help ensure that explanations accurately reflect current clinical practice, diagnostic reasoning, and treatment pathways. Patient advocacy groups (PAGs), meanwhile, bring lived experience. They can identify language that feels confusing, overly technical, insensitive, or disconnected from what patients actually experience. Content developed only through a clinical lens can become too technical; content shaped without sufficient clinical input can lose scientific precision.

A joint advisory approach can bridge these perspectives early. KOLs and PAG representatives can review the proposed structure before full content development begins, with clinicians testing scientific accuracy and patient representatives evaluating clarity, tone, sequence, and relevance. Importantly, patient involvement should occur alongside clinical input rather than after a near-final document has already been approved. When patient feedback arrives only at the end, it often results in minor wording changes rather than the structural improvements that can genuinely improve understanding.

Step Three: Choosing the Right Digital Format

Accurate and relevant information can still fail if it is delivered in the wrong format. Patient communication increasingly takes place in a digital environment in which people expect information to be accessible on demand, easy to navigate, and suitable for mobile devices. A long document may remain valuable for some purposes, but it should no longer be the default response to every educational need.

Format should follow the stage of the patient pathway. Someone facing a new and uncertain diagnosis may benefit from a short visual explainer describing what happens next. A patient already established on treatment may be ready for a more detailed interactive resource covering monitoring or long-term management. Podcasts can provide space for deeper discussion and can combine expert and patient voices, while digital portals allow individuals to return to information as questions arise.

Accessibility also extends beyond format. Multilingual delivery is increasingly important for organisations working across markets, but effective localisation requires more than direct translation. References to referral routes, specialist services, diagnostic procedures, and expectations of care may need adaptation to the local healthcare system and cultural context. The central principle is simple: the format must match the patient’s moment in the journey. Even excellent scientific information can fail when delivered at the wrong time, at the wrong level of complexity, or through a channel that patients are unlikely to use.

Measuring Whether It Is Working

Patient education should be evaluated by what patients understand, not simply by how much content an organisation produces. Numbers of brochures, webpage visits, videos, or downloads can demonstrate reach, but they provide limited evidence that communication has solved the information problem it was designed to address.

A stronger measurement framework connects outcomes directly to the knowledge gaps identified at the beginning. Engagement rates and video completion can provide useful operational information, while pre- and post-education assessments can show whether understanding has improved. Patient feedback can identify remaining areas of uncertainty, and where appropriate, organisations may also examine changes in engagement with care, adherence, or confidence in navigating the treatment pathway.

For example, a diagnostic education video may receive thousands of views, but the more meaningful measure is whether patients who previously misunderstood the diagnostic pathway demonstrate greater understanding after watching it. This creates a clear cycle: identify the gap, design the intervention, measure whether the gap narrowed, and refine the content accordingly. Patient education then becomes an evidence-informed process rather than simply a communications output.

Conclusion: Why This Belongs on Every Medical Affairs Agenda

Medical Affairs is moving beyond traditional patient education towards a more deliberate model of scientific communication. The process begins by understanding what patients already know and where uncertainty exists, particularly around diagnosis and the care pathway. Clinical experts and patient advocacy groups can then shape information together before digital formats are selected around the needs of patients at different stages of their journey.

The organisations that succeed will not begin by asking which brochure, video, podcast, or digital platform to create. They will begin with the knowledge gap, validate the scientific message with KOLs and the lived experience with PAGs, and only then determine how that information should be delivered. This sequence transforms patient education from a downstream communications activity into an integral part of Medical Affairs strategy.

When used effectively, Medical Affairs becomes more than a communicator of scientific data. It becomes the bridge that allows complex evidence to become understandable, relevant, and useful to the people ultimately affected by it. Science speaks most effectively when patients can understand what it means for their own journey.